Neuromuscular junction proteins

Neuromuscular junction proteins encompass a variety of molecules critical for the formation, function, and maintenance of the neuromuscular junction—the synapse that links motor neurons and skeletal muscle fibers. Principal proteins in this context include nicotinic acetylcholine receptors (nAChRs), which mediate neurotransmission; acetylcholinesterase (AChE), which terminates the synaptic signal; agrin, muscle-specific kinase (MuSK), and lipoprotein receptor-related protein 4 (LRP4), which are essential for postsynaptic development and receptor clustering; and structural scaffolding molecules like rapsyn[1][2][3][6]. Dysfunction in these proteins is implicated in several neuromuscular diseases, notably myasthenia gravis. However, "neuromuscular junction proteins" is not a single molecular entity and thus is not a canonical therapeutic target but rather a collective, functional designation for a group of interacting molecules at this specialized synapse[1][2][3][5][6].

Other names

Neuromuscular junction component proteinsNMJ proteinsSynaptic proteins (neuromuscular)Junctional proteins (neuromuscular)

Inhibition of acetylcholinesterase increases acetylcholine concentration, enhancing synaptic transmission; Blockade or activation of postsynaptic nicotinic acetylcholine receptors (nAChRs); Immunosuppression for autoimmune attack against junctional proteins